Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Theravance Biopharma Inc.

    NASDAQ: TBPH · Real-Time Price · USD
    13.60
    0.45 (3.42%)
    At close: Aug 18, 2025, 3:59 PM
    13.85
    1.88%
    After-hours: Aug 18, 2025, 07:49 PM EDT

    Theravance Biopharma Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -56.42M -55.19M -92.82M -199.43M
    Depreciation & Amortization
    		 3.62M 4.26M 7.02M 9.71M
    Stock-Based Compensation
    		 21.39M 25.37M 39.73M 62.06M
    Other Working Capital
    		 20.57M -8.35M 46.68M -11.46M
    Other Non-Cash Items
    		 7.09M 3.7M -183.28M 3.86M
    Deferred Income Tax
    		 -7.57M 3.21M n/a -44.48M
    Change in Working Capital
    		 20.36M -8.34M 42.35M -39.58M
    Operating Cash Flow
    		 -11.54M -27M -186.99M -207.86M
    Capital Expenditures
    		 -332K -2.49M -572K -3.41M
    Cash Acquisitions
    		 n/a n/a 4.58M 6K
    Purchase of Investments
    		 -143.03M -134.53M -103.14M -158.31M
    Sales Maturities Of Investments
    		 155.65M 102.81M 158.02M 286.2M
    Other Investing Acitivies
    		 n/a 1.51M 1.1B 127.9M
    Investing Cash Flow
    		 12.28M -32.7M 1.15B 124.49M
    Debt Repayment
    		 n/a n/a -631.6M -10.73M
    Common Stock Repurchased
    		 -3.1M -199.55M -132.28M -9.06M
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 508K 618K 5.08M 3.47M
    Financial Cash Flow
    		 -2.5M -198.93M -758.81M 91.86M
    Net Cash Flow
    		 -1.75M -258.63M 208.21M 8.5M
    Free Cash Flow
    		 -11.87M -29.48M -187.56M -211.26M

    Add to Watchlist